Cancers
Aspirin May Interact with Cells' DNA Modifications to Alter Breast Cancer Outcomes
New findings suggest that women with specific DNA characteristics in certain areas of the genome may live longer if they take aspirin before they are diagnosed with breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings point to the need for studies on the potential of aspirin to prevent or treat breast cancer in some individuals.
Latest Research Articles
Endometrial Diseases Can Be Imitated in a Lab Dish, New Study Shows
ICR Claims New Gene Test Could Detect Prostate Cancer Patients
What If You Could Spot Skin Cancer Before It Got Too Serious?
Scientists Discover 'Switch' that Helps Breast Cancer Spread Around the Body
Researchers Advance Search for Laboratory Test to Predict Spread of Breast Cancer
Pain Management Protocol Sends 92% of Cancer Surgery Patients Home without Opioids
Cancer Drug Could be Repurposed to Provide Treatment for Brain Aneurysms
A New Approach to Targeting Cancer Cells
Researchers Discover the Achilles' Heel of an Aggressive Brain Cancer
Exposing Cancer's Metabolic Addictions
Biology Filled Anime 'Cells At Work!' Gets Praise From Cancer Researcher
New Cancer Vaccine Tested 100 Percent Effective In Mice
MOST POPULAR
-
Meet Romulus and Remus: Dire Wolf Pups Resurrected with Ancient DNA, Thanks to Colossal Biosciences
-
Meet The Dire Wolf Trio Remus, Romulus And Khaleesi: How A Texas Lab Revived An Extinct Species
-
Massive New Jersey Wildfire Devastates 8,500 Acres, Threatens Wildlife and Communities Amid Historic Drought
